Table 2 Characteristics of enrolled patients.
Disease | Number of cases (n) | Female (n) | Age (years) | Proteinuria (g/g Cr) | Serum alb (g/dL) | eGFR (ml/min/1.73 m2) |
|---|---|---|---|---|---|---|
IgA nephropathy | 17 | 9 | 12 (7–15) | 1.1 (0.0–4.9) | 3.8 (3.1–4.9) | 107 (79–130) |
IgA vasculitis with nephritis | 6 | 2 | 5 (5–15) | 3.8 (0.2–15.9) | 3.0 (1.7–4.4) | 115 (103–139) |
Lupus nephritis | 9 | 7 | 13 (8–18) | 0.7 (0.1–5.5) | 3.3 (2.7–4.5) | 108 (63–198) |
MPGN | 5 | 2 | 13 (5–16) | 1.5 (0.2–2.8) | 3.6 (1.1–4.6) | 122 (37–201) |
Membranous nephropathy | 2 | 0 | 5 (3–7) | 1.9 (1.8–2.1) | 3.4 (3.2–3.5) | 119 (110–128) |
Idiopathic nephrotic syndrome | 11 | 6 | 7 (2–16) | 0.1 (0.0–29.1) | 4.1 (1.7–4.6) | 109 (87–142) |
Oligomeganephronia | 3 | 1 | 15 (12–16) | 0.7 (0.3–1.2) | 4.2 (4.1–4.5) | 62 (58–66) |
Alport syndrome | 2 | 2 | 3.5 (3–4) | 0.3 (0.2–0.4) | 4.4 (4.2–4.5) | 134 (126–142) |
Dense deposit disease | 1 | 0 | 10 | 1.4 | 3.6 | 78 |
Crescentic glomerulonephritis | 1 | 1 | 17 | 3.3 | 4.0 | 102 |
C3 glomerulonephritis | 1 | 0 | 12 | 0.1 | 4.6 | 94 |
PSAGN | 1 | 1 | 8 | 10.8 | 1.9 | 42 |
Hemolytic uremic syndrome | 1 | 1 | 4 | 1.1 | 4.9 | 55 |
